Anil Batta
In patients with neurological injuries, acute treatment of cerebral edoema and high intracranial pressure is a prevalent problem. There are few practical suggestions for selecting and monitoring therapies for the initial therapy of cerebral edoema for maximum efficacy and safety. In the acute treatment of cerebral edoema, this guideline assesses the usefulness of hyperosmolar drugs (mannitol, HTS), corticosteroids, and certain non-pharmacologic interventions. Clinicians must be able to choose appropriate medications for the first management of cerebral edoema based on the current information while balancing efficacy and safety. Methodologies: The Neurocritical Care Society recruited experts in neurocri. Using the PICO model, the group came up with 16 clinical questions about the early therapy of cerebral edoema in distinct neurological lesions. Through July 2018, a research librarian conducted a comprehensive literature search. The panel reviewed the identified articles for inclusion in each PICO question and abstracted the necessary data for relevant publications.
